NYCB 2017 Annual Report

108 The following tables provide additional information regarding the methods used to evaluate the Company’s loan portfolio for impairment: (in thousands) Mortgage Other Total Loans Receivable at December 31, 2017: Loans individually evaluated for impairment $ 31,747 $ 48,810 $ 80,557 Loans collectively evaluated for impairment 36,278,241 2,000,224 38,278,465 Total $36,309,988 $2,049,034 $ 38,359,022 (in thousands) Mortgage Other Total Loans Receivable at December 31, 2016: Loans individually evaluated for impairment $ 29,660 $ 18,592 $ 48,252 Loans collectively evaluated for impairment 35,402,029 1,900,158 37,302,187 Acquired loans with deteriorated credit quality 1,614,755 89,140 1,703,895 Total $37,046,444 $2,007,890 $39,054,334 Allowance for Losses on Non-Covered Loans The following table summarizes activity in the allowance for losses on non-covered loans for the twelve months ended December 31, 2017 and 2016: December 31, 2017 2016 (in thousands) Mortgage Other Total Mortgage Other Total Balance, beginning of period $125,416 $32,874 $158,290 $124,478 $22,646 $147,124 Charge-offs (375) (62,975) (63,350) (170) (3,413) (3,583) Recoveries 605 1,558 2,163 1,272 1,603 2,875 Provision for (recovery of) non- covered loan losses 2,629 58,314 60,943 (164) 12,038 11,874 Balance, end of period $128,275 $29,771 $158,046 $125,416 $32,874 $158,290 See Note 2, “Summary of Significant Accounting Polices” for additional information regarding the Company’s allowance for losses on non-covered loans.